相关实验视频
Updated: Jun 11, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.8K
对于前列腺癌的微RNA研究最近的进展.
Fan Yuan1, Yue Hu2, Yanmei Lei3
1Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan, People's Republic of China.
Discover oncology
|September 27, 2024
概括
前列腺癌 (PCa) 的诊断和治疗正在通过microRNAs (miRNAs) 得到改善. 这些分子在PCa中表现出改变,有助于早期检测,预后和个性化治疗,包括与传统中医药的整合.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌 (PCa) 是一个日益严重的健康问题,患病率越来越高.
- 目前的诊断方法如PSA测试和DRE在精度上有局限性.
- 在PCa患者中观察到改变的微RNA (miRNA) 表达,这表明潜在的生物标志物有用性.
研究的目的:
- 审查前列腺癌患者的miRNA表达模式.
- 探索miRNAs在PCa诊断和预后中的作用.
- 研究miRNAs在PCa治疗策略中的应用,包括与中国传统医学 (TCM) 的整合.
主要方法:
- 对前列腺癌中miRNA表达研究的文献综述.
- 对用于PCa诊断和预后的miRNA生物标志物的研究分析.
- 检查关于miRNA向疗法的研究及其与TCM的整合.
主要成果:
- 特定的miRNAs在PCa中表现出改变的表达水平,表明诊断和预后潜力.
- 在TCM中,miRNAs在综合征分化和治疗有效性评估方面表现有前途.
- 针对miRNA的疗法正在进步,使个性化PCa治疗成为可能.
结论:
- miRNAs代表了前列腺癌诊断和预后的有希望的生物标志物.
- 将miRNA与TCM集成为PCa提供了新的治疗途径.
- 针对miRNAs有助于为前列腺癌提供个性化和精确的治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

